Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2014 / Oct / Vitamin D implicated in Schizophrenia
Neurology Neurology Genetics and epigenetics Biochemistry and molecular biology Omics Molecular Pathology

Vitamin D implicated in Schizophrenia

Environmental Factors Low levels of vitamin D may be linked to schizophrenia risk

By Roisin McGuigan 10/02/2014 1 min read

Share

0114-204-MAIN.IMG

A group of Iranian researchers took a different approach: delving further into the proposed link between vitamin deficiency and schizophrenia (1). “Vitamin D deficiency is relatively prevalent across the world and is associated with several disorders, including depression. So we were interested in exploring its role in psychiatric health further,” explains Ahmad Esmaillzadeh, lead author of the study.

The team reviewed 19 studies that examined the blood of a total of 2,804 participants. Apparently, the work represents the first comprehensive meta-analysis of its kind and yielded unanticipated results. “We were very surprised by the significant 2.16 times increased risk of schizophrenia in vitamin D deficient individuals,” says Esmaillzadeh.

It has long been suspected that vitamin D levels may affect the developing brain, and low levels prenatally may predispose to schizophrenia (2). Deficiency during development has also been suggested as a possible explanation for the varying incidences of schizophrenia in different populations – such as people born at different times of year or in different latitudes. Esmaillzadeh says that the next step for his team will be to trial vitamin D supplementation in people with schizophrenia, as well as investigating maternal and neonatal serum vitamin D in relation to the condition in later life.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. G. Valipour et al., “Serum Vitamin D Levels in Relation to Schizophrenia: a Systematic Review and Meta-Analysis of Observational Studies”, J. Clin. Endocrinol. Metab. (2014). [Epub ahead of print]. J. J. McGrath et al., “Developmental Vitamin D Deficiency and Risk of Schizophrenia: a 10 Year Update”, Schizophr. Bull., 36, 1073-78 (2010).

About the Author(s)

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as an Associate Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

More Articles by Roisin McGuigan

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Shapeshifting Cancer
Neurology
The Shapeshifting Cancer

February 24, 2022

1 min read

Understanding the heterogeneity and plasticity of glioblastoma

Image of the Month
Neurology
Image of the Month

October 21, 2016

1 min read

Who Will Be The Caretakers?
Neurology
Who Will Be The Caretakers?

August 4, 2022

3 min read

Recent allegations of image manipulation in a major Alzheimer’s disease paper reaffirm the importance of research integrity

Getting to the Genetic Core of Autism
Neurology
Getting to the Genetic Core of Autism

August 15, 2022

2 min read

Investigating the genotype-phenotype relationship in autism to improve our understanding of heterogeneity

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.